Participating Faculty: Antibody-Drug Conjugates in Advanced/Metastatic Non–Small Cell Lung Cancer

Faculty

Millie Das, MD

Department of Oncology

Stanford University

Stanford, CA

Roy S. Herbst, MD, PhD

Department of Medical Oncology

Yale School of Medicine

New Haven, CT

Stephen V. Liu, MD

Department of Hematology Oncology

Georgetown Lombardi University Medical Center

Washington, DC

Solange Peters, MD, PhD

Department of Oncology

University Hospital of Lausanne

Lausanne, Switzerland

Julia Rotow, MD

Lowe Center for Thoracic Oncology

Dana-Farber Cancer Institute

Boston, MA

Faculty and Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Millie Das, MD

CONSULTANCIES OR PAID ADVISORY BOARDS

AstraZeneca; Boehringer Ingelheim; Cellsight Technologies, Inc; EMD Serono; Lilly USA; Genentech, Inc; Gilead Sciences, Inc; Jazz Pharmaceuticals, Inc; Johnson & Johnson; Merck & Co, Inc; Merus; Natera, Inc; Novartis; Nuvation Bio Inc; OncoHost; RayzeBio, Inc; Regeneron Pharmaceuticals Inc; Summit Therapeutics Inc.

Roy S. Herbst, MD, PhD

CONSULTANCIES OR PAID ADVISORY BOARDS

AstraZeneca; Amgen Inc; ArriVent BioPharma; Bristol Myers Squibb; Candel Therapeutics; Catalym; Checkpoint Therapeutics, Inc; Cybrexa Therapeutics; Lilly USA; Genentech, Inc; Gilead Sciences, Inc; Johnson & Johnson; Mediflix; Merck & Co, Inc; Neuvogen, Inc; NextCure, Inc; Normunity Inc; NovaBridge Biosciences; Novartis; Pfizer Inc; Regeneron Pharmaceuticals Inc; Roche; Sanofi.

STOCK OWNERSHIP

Checkpoint Therapeutics, Inc; Immunocore Holdings plc.

Stephen V. Liu, MD

CONSULTANCIES OR PAID ADVISORY BOARDS

AbbVie Inc; Amgen Inc; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo, Inc; Genentech, Inc; Gilead Sciences, Inc; GSK plc; Guardant Health, Inc; Jazz Pharmaceuticals, Inc; Johnson & Johnson; Merck & Co, Inc; Merus; Natera, Inc; Novartis; Nuvalent; OSE Immunotherapeutics; Pfizer Inc; PharmaMar; Regeneron Pharmaceuticals Inc; Revolution Medicines, Inc; SystImmune, Inc; Takeda Pharmaceutical Company Limited.

GRANTS RECEIVED

AbbVie Inc; Alkermes, AstraZeneca; Avenzo Therapeutics; BioNTech; Bristol Myers Squibb; Cogent Biosciences, Inc; Duality Biologics; Ellipses Pharma; Genentech, Inc; Gilead Sciences, Inc; MediLink Therapeutics; Merck & Co, Inc; Merus; Nuvalent; Nuvation Bio Inc; OSE Immunotherapeutics; Puma Biotechnology, Inc; Synthekine; SystImmune, Inc.

Solange Peters, MD, PhD

CONSULTANCIES OR PAID ADVISORY BOARDS

AbbVie Inc; Amgen Inc; Arcus Biosciences, Inc; AstraZeneca; Bayer; BeOne Medicines; BioNTech; Bicycle Therapeutics; Biocartis; BioInvent; Blueprint Medicines Corporation; Boehringer Ingelheim; Bristol Myers Squibb; Clovis Oncology; Daiichi Sankyo, Inc; Debiopharm; Lilly USA; F-Star Therapeutics; Foundation Medicine, Inc; Genentech, Inc; Genmab; Genzyme; Gilead Sciences, Inc; GSK plc; HUTCHMED; Illumina, Inc; Incyte; Ipsen Pharma; iTeos Therapeutics Inc; Johnson & Johnson; Merck Serono; Merck Sharp & Dohme Federal Credit Union; Novartis; Novocure; Nuvalent; Nuvation Bio Inc; Nykode Therapeutics; Oncoinvent; Pfizer Inc; PharmaMar; Promontory Therapeutics; Qlucore; Regeneron Pharmaceuticals Inc; Sanofi; Takeda Pharmaceutical Company Limited; Zymeworks Inc.

LECTURE FEES FOR SPEAKING AT THE INVITATION OF A COMMERCIAL SPONSOR

AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Foundation Medicine, Inc; Genentech, Inc; GSK plc; Illumina, Inc; Ipsen Pharma; Lilly USA; Merck Sharp & Dohme Federal Credit Union; Novartis; Pfizer Inc; Sanofi; Takeda Pharmaceutical Company Limited.

GRANTS RECEIVED

Amgen Inc; Arcus Biosciences, Inc; AstraZeneca; BeOne Medicines; Boehringer Ingelheim; Bristol Myers Squibb; Genentech, Inc; GSK plc; iTeos Therapeutics Inc; Lilly USA; Merck Sharp & Dohme Federal Credit Union; Mirati Therapeutics, Inc; Pfizer Inc; PharmaMar; Promontory Therapeutics.

Julia Rotow, MD

CONSULTANCIES OR PAID ADVISORY BOARDS

Amgen Inc; AstraZeneca; BioAtla Inc; BlossomHill Therapeutics, Inc; Boehringer Ingelheim; Bristol Myers Squibb; Catalyst Pharmaceuticals, Inc; Daiichi Sankyo, Inc; G1 Therapeutics, Inc; Genentech, Inc; Guardant Health, Inc; Jazz Pharmaceuticals, Inc; Johnson & Johnson; Merus; Novocure; Nuvalent; Nuvation Bio Inc; Pfizer Inc; Regeneron Pharmaceuticals Inc; Sanofi; Summit Therapeutics Inc; Takeda Pharmaceutical Company Limited.

LECTURE FEES FOR SPEAKING AT THE INVITATION OF A COMMERCIAL SPONSOR

AstraZeneca; Daiichi Sankyo, Inc; Pfizer Inc.

CONTRACT FOR INSTITUTIONAL RESEARCH

AbbVie Inc; Altor BioSciences Corp; AstraZeneca; Bicycle Therapeutics; BioAtla Inc; Black Diamond Therapeutics; BlossomHill Therapeutics, Inc; Blueprint Medicines Corporation; Bristol Myers Squibb; Duality Biologics; Enliven Therapeutics; EpimAb Biotherapeutics; ImmunityBio, Inc; Loxo Oncology, Inc; ORIC Pharmaceuticals, Inc; RedCloudBio Co, Ltd; Regeneron Pharmaceuticals Inc; Summit Therapeutics Inc; Synthekine.